Phage mimetic self-assemblies deliver nucleic acids to the brain
The brain is a privileged organ heavily protected by a complex cellular barrier termed the blood–brain barrier (BBB), which selectively excludes most blood-borne substances from entering the brain. The BBB accounts for the failure of a large number of promising neurotherapeutics, including nucleic acid medicines such as RNA interference (siRNA). In the past decade, we have witnessed vested efforts in finding viable strategies for drug delivery to the brain through minimally invasive routes of administration and without compromising the integrity of the BBB. To this end, our own efforts have recently introduced phage mimetics as new types of ’simple-by-design’ and...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!